...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
DVA NYSE 🇺🇸 US
DaVita Inc.
Healthcare
Not a Dip
Price Zone: Hold / Watch
🔒 Full AI Analysis — Pro
28Score
DipBuster Score™
$183.64 $2.46 (-1.32%) Live price · Source: Yahoo
52-Week Position
$101.00 56% of range $247.49
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$247.49
52W Low$101.00
DipBuster Brief Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (56% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position56% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at DaVita Inc. (DVA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-09-22 Maughan David Paul SELL 7,501
2026-08-15 Pullin Dennis W BUY 278
2026-08-15 Moore Gregory J. BUY 278
2026-08-15 Hollar Jason M. BUY 278
2026-08-15 Arway Pamela M BUY 278
2026-08-15 Schechter Adam H BUY 278
2026-08-15 Schoppert Wendy Lee BUY 278
2026-08-15 Yale Phyllis R BUY 278
2026-08-15 Desoer Barbara J BUY 278
2026-07-31 Berkshire Hathaway Inc SELL 182,980

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$247.49
52W Low$101.00

52-Week Range

$101.00Now$247.49
56% through annual range
From 52W High−25.8%
From 52W Low+81.8%
📖 Plain English Summary
DaVita Inc. is at 56% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for DVA 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — DVA
Heuristic · balance sheet, insider filings, price data, academic research

DaVita Inc. — DipBuster Score 28/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track DaVita Inc. free

Add DVA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 17/25
Momentum & Volume 6/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
4 /100 · NEUTRAL
dip depth 4/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 28/100
📊 Run a full check in the AI analysis tab for a deeper look.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →